不同的协生药物给药方法对科布-500 brojlers 的生长,尸体特征,骨髓组织形态测量和血液生物化学的影响
Arjun Acharya1, Bhuminand Devkota2, Hom Bahadur Basnet3
1Department of Animal Nutrition and Fodder Production, Agriculture and Forestry University, Faculty of Animal Science, Veterinary Science and Fisheries, Rampur, Chitwan, 00977 Nepal.
Veterinary world
|July 30, 2024
概括
协生菌可以改善肉的生长,肠道健康和料效率. 不同的施用方法,不包括in ovo,提高性能和降低胆固醇,但in ovo的使用可能会降低化能力.
科学领域:
- 动物科学动物科学
- 微生物学 微生物学
- 禽类营养 养 禽类营养
背景情况:
- 抗生素耐药性和肠道感染需要像家禽中的共生菌这样的替代品.
- 协生菌,结合益生菌和益生菌,支持有益的微生物生长.
研究的目的:
- 评估Cobb-500肉的最佳协生传递方法.
- 评估协生菌对生长,组织形态学和血液学的影响.
主要方法:
- 使用随机设计进行了两项试验.
- 包括在卵子注射,水和料中注射共生菌的方法.
- 分析了生长,料摄入量,水消耗以及组织/血液参数.
主要成果:
- 在卵子中,共生菌降低了化能力,但在以后的试验中改善了生长.
- 通过水或料进行协生生菌的施用,增强了生长,皮质小长度和料效率.
- 血液中的胆固醇水平在使用共生菌时降低.
结论:
- 当通过水或料给药时,共生菌可显著改善肉的表现和肠道健康.
- in ovo方法对化能力产生了负面影响.
- 协生菌为增强肉生产提供了抗生素的可行替代品.
相关概念视频
Bioavailability: Influencing Factors
679
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
679
Bioavailability Study Design: Single Versus Multiple Dose Studies
383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
Measurement of Bioavailability: Pharmacokinetic Methods
517
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
517
Measurement of Bioavailability: Pharmacodynamic Methods
1.0K
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K
Drug Product Performance: In Vitro–In Vivo Correlation
431
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
431
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394


